See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2019_GYRE_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 123,991,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 386,000 |
| 3 | remainder_Assets | 543,000 |
| 4 | LiabilitiesCurrent | 4,801,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 174,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,629,452 |
| 9 | ResearchAndDevelopmentExpense | 19,500,256 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 5,406 |
| 12 | remainder_NetIncome | 2,809,202 |
| 13 | remainder_ComprehensiveNetIncome | -2,384 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 124,920,000 |
| 1 | Liabilities | 4,975,000 |
| 2 | Expenses | 32,129,708 |
| 3 | Revenues | 5,406 |
| 4 | StockholdersEquity | 119,945,000 |
| 5 | NetIncome | -29,315,100 |
| 6 | ComprehensiveNetIncome | -29,316,292 |
| 7 | BaseVar | 82,420,850 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.57 |
| 9 | EconomicCapitalRatio | 4.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
